The emerging problems posed by antibiotic resistance complicate the treatment regime required for wound infections and are driving the need to develop more effective methods of wound management. There is growing interest in the use of alternative, broad spectrum, pre-antibiotic antimicrobial agents such as essential oils (e.g., tea tree oil, TTO) and metal ions (e.g., silver, Ag + ). Both TTO and Ag + have broad spectrum antimicrobial activity and act on multiple target sites, hence reducing the likelihood of developing resistance. Combining such agents with responsive, controlled release delivery systems such as hydrogels may enhance microbiocidal activity and promote wound healing. The advantages of using chitosan to formulate the hydrogels include its biocompatible, mucoadhesive and controlled release properties. In this study, hydrogels loaded with TTO and Ag + exhibited antimicrobial activity against P. aeruginosa, S. aureus and C. albicans. Combining TTO and Ag + into the hydrogel further improved antimicrobial activity by lowering the effective concentrations required, respectively. This has obvious advantages for reducing the potential toxic effects on the healthy tissues surrounding the wound. These studies highlight the feasibility of delivering lower effective concentrations of antimicrobial agents such as TTO and Ag + in ionically crosslinked chitosan hydrogels to treat common wound-infecting pathogens.
Introduction
The increasing occurrence of antibiotic-resistant strains and reports of hospital cross-infection further complicate current practices in wound management. Statistics show that acute and chronic wounds affect approximately 2% of the population, with treatment costs taking up to 4% of the overall health care budget [1] . In Europe, the cost of managing a patient with chronic wounds can cost up to €6000-€10,000 per annum [2] .
Acute and chronic wounds require relatively lengthy treatment with antibiotics which carry the attendant risk of developing drug resistance. Additionally, hypersensitivity reactions to antibiotics and the lack of access to new treatments within the health care industry make the care of such patients difficult [3] . This severely compromises the patient's quality of life and also creates a significant financial burden for the economy. There are, therefore, several forces driving the need to find alternative approaches to conventional wound management.
Smith and Nephew Healthcare Limited, Hull, UK), have been successfully used for the treatment of burn wound infections. In addition, controlled release delivery systems have also incorporated Ag + to reduce infection and improve the wound healing process. Some current examples of silver-containing wound dressings include DuoDERM ® (hydrocolloids, ConvaTec, Skillman, NJ, USA), Aquacel ® Ag (hydrofibre dressings containing antimicrobial Ag + , ConvaTec, Skillman, NJ, USA), Tegaderm TM (films, 3M United Kingdom PLC, Bracknell, UK), Vaseline TM (gauze, Unilever, London, UK), Sorbsan ® (alginates, Bertel Pharmacceuticals, Research Triangle Park, NC, USA), Lyofoam ® C (foam dressing, ConvaTec, Skillman, NJ, USA) and Nu-Gel TM (hydrogels, Johnson and Johnson Wound Management, Somerville, NJ, USA) [23, 24] . As is common with many drug treatments, over-exposure to Ag + can trigger unwelcome side effects. Long-term topical exposure to high concentrations of Ag + leads to a build-up of metallic silver (Ag 0 ) in the dermis, causing an irreversible blue-grey discolouration of the skin (argyria). This is particularly pronounced in areas exposed to sunlight which accelerates the photo-reduction and deposition of Ag 0 [25] [26] [27] . Some patients treated with silver-containing dressings reported the occurrence of skin rashes, stinging and burning sensations [28] . Other more serious problems associated with the topical application of silver include disturbances in electrolyte concentration resulting in hyponatremia or hypochloremia [20] .
Hydrogels are three-dimensional crosslinked polymer networks which can imbibe large amounts of water or biological fluids [4, 29] . These biodegradable gels maintain their structure during the exchange of fluids and provide controlled release of drugs via pores in the polymer network [29, 30] . When applied to wounds, hydrogels can absorb exudate while maintaining a well-oxygenated and moist environment [31, 32] . The parameter that dictates hydrogel formation is the constituent polymer's aqueous solubility, whether it is from natural or synthetic sources. Chitosan, a natural polymer amenable to hydrogel formation, is a linear copolymer of β(1-4)-linked 2-acetamido-2-deoxy-D-glucopyranose and 2-amino-2-deoxy-D-glyco-pyranose monomers [32] . Chitosan has good biocompatibility, biodegradability, mucoadhesive and low toxicity properties. It forms a barrier to gases and aromas in dry conditions, and is used to prepare membranes, films, microparticles, nanofibrils, scaffolds and gels [33] [34] [35] . Chitosan's properties can be adapted to suit a wide variety of antimicrobial delivery systems for medical, food, coating and packaging applications. In addition, chitosan has bacteriostatic properties against fungi and Gram-negative bacteria. The advantages of using chitosan for wound management applications are its biocompatible, mucoadhesive and controlled release properties. This allows cell adhesion and interactions which promote the growth of dermal and epidermal layers by inducing cell migration as well as proliferation [35, 36] .
The useful properties of alternative antimicrobial agents, together with advances in drug delivery technologies, may be able to enhance and expand the medical applications of these agents. Combining these alternative antimicrobial agents with advanced drug delivery systems aims to: (1) promote bioavailability of the agent at microbiocidal concentrations; (2) reduce drug concentration to enhance safety and practicality of application; (3) minimise scarring and promote wound healing processes; (4) reduce discomfort and pain in consideration of the patients' psychological needs; and (5) decrease the frequency of dressing changes [37] . These aims would increase convenience, provide less opportunity for infection and/or reinfection of the wound and ultimately reduce treatment costs.
Therefore, the aims of this investigation were to examine the in vitro antimicrobial efficacy of hydrogels incorporating TTO alone and in combination with Ag + (as silver nitrate, AgNO 3 ) against representative wound-infecting organisms, namely P. aeruginosa, S. aureus and C. albicans. We report here on the characterisation and optimisation of both preparation and formulation techniques of a hydrogel-based delivery system for controlled release of antimicrobially active Ag + and TTO. 
Materials and Methods

Preparation of Microbial Cultures
Sterile tryptone soy broth (TSB), tryptone soy agar (TSA), malt extract broth (MEB) and malt extract agar (MEA) were obtained from Lab M, Lancashire, UK, and prepared according to manufacturer's recommendations. Overnight culture of P. aeruginosa (NCIB 8295) was prepared by aseptically inoculating 50 mL of sterile TSB and incubating overnight in an orbital shaker at 37˝C. Similarly, overnight cultures of S. aureus (NCIB 6571) in TSB and C. albicans (NCYC 854) in MEB were also similarly prepared.
Hydrogel Formulation and Characterisation
Sodium phosphate (monobasic monohydrate, Sigma Aldrich, Darmstadt, Germany), Na-P solutions (25% and 50% w/v) were prepared in sterile distilled water. Medium-or low-viscosity chitosan (Sigma Aldrich, Darmstadt, Germany) solutions (1.25% and 2.5% w/v) were prepared in 1.0% v/v glacial acetic acid (BDH, Poole, UK). Phosphate buffer saline (PBS) (Invitrogen Corporation, Camarillo, CA, USA) was prepared according to manufacturer's recommendation and autoclaved prior to use.
Ionically crosslinked chitosan hydrogels were prepared by vigorous magnetic stirring of various ratios of chitosan (medium or low viscosity, 1.25% or 2.5% w/v), Na-P (25% or 50% w/v) and 10% w/v poly(vinyl alcohol) (PVA) 13-23 kDa, PVA 13´23 , or 31-50kDa, PVA 31´50 , (Sigma Aldrich, Darmstadt, Germany) solutions. After mixing for 2 min the gelling mixtures were passed through 0.45 µm sterile syringes, transferred into sterile Petri dishes, covered and allowed to set for a minimum of 2 h.
The physical stability of each formulation was assessed firstly by confirming the formation of a uniform hydrogel. Following that, discs of hydrogel (diameter 8 mm) were cut and placed in a clean Petri dish with 20 mL of distilled water. Hydrogel formulation discs that maintained their shape, could easily be cut out and handled, as well as remaining stable after incubation in water were chosen for further study.
TTO:PVA (poly[vinyl alcohol]) emulsions were prepared by probe sonicating (Bandelin Sonopuls HD2200, Bandelin Electronic, Berlin, Germany) TTO and 10% w/v PVA (35:65 v/v ratio) for 1 min. TTO:PVA-loaded hydrogels were prepared by substituting or adding sufficient emulsified TTO as part of the PVA component in the formulations to produce hydrogels with final TTO concentration of 5% or 7% v/v.
TTO-encapsulated hydrogel discs (8 mm diameter) were incubated in 20 mL PBS at room temperature. At time zero and at every hour up to 6 h, 6 mL of PBS was sampled, and replaced by 6 mL of fresh PBS. Further samples were taken after 7.5 and 24 h. Subsequently the amount of TTO and chitosan released from the hydrogels was quantified using the monoterpene and ninhydrin quantification assays, respectively.
Vanillin Assay for the Determination of Monoterpene Release from TTO
A colorimetric method for determining the total monoterpene content using 2.5% w/v vanillin (ReagentPlus ® grade, Acros Organics, Geel, Belgium) in concentrated sulphuric acid (Philip Harris Scientific, Lichfield, UK) was adapted from Doneva-Šapceska et al., 2006 [38] . Vanillin reagent (2.5 mL) was added to test tubes containing 5 mL of sample, mixed and heated in a 60˝C water bath for 20 min. The samples were then cooled in an ice-water bath to 25˝C. A blank sample was also prepared using 5 mL distilled water. Absorbance of the samples was measured spectrophotometrically at 608 nm (Cecil 1000 Series, Cecil Instruments, Cambridge, UK).
Chitosan Assay (Ninhydrin Assay)
Quantification of chitosan was performed using a colorimetric ninhydrin assay adapted from Leane et al., 2004 [39] . Lithium acetate buffer (4 M) was prepared by dissolving 4.08 g of lithium acetate dihydrate (Aldrich grade 98%, Sigma Aldrich, Milwaukee, WI, USA) in 10 mL distilled water and adjusted to pH 5.2 using glacial acetic acid. Ninhydrin reagent was prepared by adding 0.8 g ninhydrin (ACS reagent, Sigma Aldrich, Bangalore, India) and 0.12 g hydrindantin (Sigma Aldrich, Vienna, Austria) in 30 mL dimethylsulphoxide (DMSO) (Calbiochem, EMD Chemicals, San Diego, CA, USA) into 10 mL of 4 M lithium acetate buffer. Ninhydrin reagent (0.5 mL) was added to 0.5 mL of sample in a capped test tube. Blanks sample were prepared by substituting the sample with distilled water. The contents were mixed and heated in boiling water for 30 min, cooled and 15 mL of 50:50 ethanol:water cosolvent mixture added. The contents of each tube were vortexed for 15 s to ensure complete oxidization of the excess hydrindantin, prior to measuring absorbance spectrophotometrically at 570 nm (Cecil 1000 Series). The results were analysed by fitting the data to zero order, first order, Higuichi and Korsmeyers-Peppas equations [40] to deduce the monoterpene release profile from the hydrogels. Following the initial trial formulations confirming the feasibility of hydrogels to deliver TTO, another batch of hydrogels containing 35% TTO: 65% PVA 30´70 v/v, Ag + and TTO:Ag + :PVA 30´70 were produced. It was found that the Ag + solutions used in the formulations also acted as the crosslinker for the hydrogels; hence, in the formulations containing Ag + , Na-P was substituted with 1% or 2% w/v AgNO 3 . Table 1 shows the detailed composition of stable hydrogels containing TTO and/or Ag + , which were used for antimicrobial studies.
Well Diffusion Assay to Determine the Antimicrobial Activity of Hydrogels
The antimicrobial effect of the agents encapsulated into hydrogels was tested using a standard well diffusion method. Overnight cultures of P. aeruginosa and S. aureus were adjusted accordingly to the following absorbance reading at 500 nm based on the British Society for Antimicrobial Chemotherapy (BSAC) disc diffusion method guidelines [41] :
Overnight cultures of C. albicans were used without dilution in the disc diffusion experiments, as they contained sufficient number of cells for the experiments. The adjusted cultures were swabbed on the surface of the agar plates in triplicate according to the BSAC disc diffusion method recommendations. A well (12 mm diameter) was aseptically bored in the middle of the agar plate using a sterile metal borer. The hydrogel was aseptically placed in the well and incubated overnight at 37˝C, prior to measuring the diameter of the zone of inhibition. Control experiments were prepared by substituting the hydrogels with those formulated without TTO:PVA and AgNO 3 . 
Results and Discussion
Appearance of Ionically Crosslinked Chitosan Hydrogels
Data from the preliminary studies showed that stable, uniform hydrogels were formed using the composition ratios as detailed in Table 2 . All the hydrogel formulations reported in Table 2 could easily be cut out as 8 mm or 12 mm diameter discs, remained stable when incubated in PBS and did not break up extensively over the incubation period. Examples of the appearance of the formulated hydrogels are shown in Figure 1 . 
Results and Discussion
Appearance of Ionically Crosslinked Chitosan Hydrogels
Cumulative Chitosan and Monoterpene Release after 24 h Incubation
The release mechanism of chitosan and monoterpene (TTO) from hydrogels was investigated as a function of hydrogel degradation. Figure 2 shows the release profiles of low-viscosity chitosan ( Figure 2A ) and medium-viscosity chitosan ( Figure 2B ) of hydrogel formulations containing 35% TTO: 65% PVA (10% w/v) emulsion. The release profiles of chitosan from formulations containing 50% TTO: 50% PVA (10% w/v) are shown in Figure 2C . Similarly, the monoterpene release profiles from the respective hydrogel formulations are shown in Figure 3 . 
The release mechanism of chitosan and monoterpene (TTO) from hydrogels was investigated as a function of hydrogel degradation. Figure 2 shows the release profiles of low-viscosity chitosan ( Figure 2A ) and medium-viscosity chitosan ( Figure 2B ) of hydrogel formulations containing 35% TTO: 65% PVA (10% w/v) emulsion. The release profiles of chitosan from formulations containing 50% TTO: 50% PVA (10% w/v) are shown in Figure 2C . Similarly, the monoterpene release profiles from the respective hydrogel formulations are shown in Figure 3 . chitosan Low-viscosity chitosan formulations showed chitosan release was between 9.72 × 10 −2 to 3.99 × 10 −1 %/mL at 24 h post-incubation (Figure 2A) . Comparatively, the amount of monoterpene Low-viscosity chitosan formulations showed chitosan release was between 9.72ˆ10´2 to 3.99ˆ10´1 %/mL at 24 h post-incubation (Figure 2A) . Comparatively, the amount of monoterpene release was fairly similar, i.e., 2.53ˆ10´1 to 3.52ˆ10´1 %/mL ( Figure 3A) . Results showed that lower-viscosity hydrogels and those formulated using PVA 13´23 (to emulsify the TTO prior to encapsulation) eroded at a higher rate (more chitosan released). The hydrogels formulated with PVA 13´23 and chitosan L1.25 released 3.99ˆ10´1 %/mL compared to 2.07ˆ10´1 %/mL in gel formulated using chitosan L2. 5 . Similarly, in hydrogels formulated with PVA 31´50 , stability was also improved in gels formulated with chitosan L2.5 , resulting in 9.72ˆ10´2 %/mL chitosan release compared to 2.99ˆ10´1 %/mL in the gel formulated using chitosan L1. 25 .
The trend of chitosan and monoterpene release from hydrogels formulated with medium-viscosity chitosan differs from the low-viscosity hydrogels. Results in Figures 2B and 3B showed that chitosan M1.25 formulations gradually released both chitosan and monoterpene over time. The formulation having a higher volume of 25% w/v Na-P (formulation C M1.25 PVA 13´23 ) displayed better stability properties, i.e., low chitosan release (low erosion) with slow release of monoterpene. In contrast, formulations with chitosan M2.5 showed a steep increase in chitosan release between 5 and 7.5 h post-incubation, resulting in the higher final amount released. Although the gels formulated with chitosan M2.5 are considered to be more stable, those formulated with PVA 13´23 (formulation C M2.5 PVA 13´23 ) may be more prone to erosion due to the lower chitosan:Na-P ratio, resulting in weaker crosslinking. Similarly, the stability of the gels may also be compromised by the chitosan-PVA chain entanglement interaction. Hence, despite the higher chitosan:Na-P ratio, the gels formulated with PVA 31´50 (formulation C M2.5 PVA 31´50 ) appear to be less stable (greater chitosan erosion) due to the dissociation of the chitosan-PVA interaction. Consequently, this also resulted in higher monoterpene release, despite the more viscous properties of these formulations within the group.
When formulating medium-viscosity hydrogels with 50% TTO:50% PVA v/v, there were observable changes in the chitosan and monoterpene release profiles ( Figures 2C and 3C ). The overall chitosan release from the formulations was lower when compared to the formulations in Figure 2B . All formulations showed gradual increase of chitosan release over time, except formulation C M1.25 PVA 31´50 in Figure 2C , which showed a steep increase between 4 and 6 h post-incubation.
Similar to the other formulations, increasing crosslinking along with increased viscosity improves hydrogel stability. These gels (C M1.25 PVA 13´23 and C M2.5 PVA 31´50 in Figure 3C ) showed a gradual increase in monoterpene release up to 5.65ˆ10´1 %/mL and 4.95ˆ10´1 %/mL, respectively. On the other hand, monoterpene release in the formulations having a lower ratio of chitosan:Na-P (less viscous) was between 7.65ˆ10´2 and 1.19ˆ10´1 %/mL. When monoterpene release for hydrogel formulations was analysed with zero order, first order, Higuchi and Korsmeyer-Peppas equations [40] , the results indicated that monoterpene release from the all the hydrogel formulations, except formulation C M1.25 PVA 13´23 , follows the zero order release with a correlation coefficient of R > 0.97, i.e., release of monoterpene was constant over time [40] . The correlation coefficients for the other models (first order release, Korsmeyers-Peppas and Higuchi models) were all <0.97 (Table 3) . Based on the mathematical modelling, the release profile of formulation C M1.25 PVA 13´23 fits the Higuichi equation (R 2 > 0.97); hence, the monoterpene was released via a diffusional process according to Fick's law [40] . Preferably, TTO-hydrogel formulations should be tailored to have lower chitosan release along with more controlled monoterpene release, thus indicating increased formulation stability with sustained delivery of TTO to maintain antimicrobial efficacy. It is evident that there are many factors which may influence the viscosity and properties of each formulation.
Well Diffusion Assay of Hydrogels Containing TTO and/or Ag +
The results from the well diffusion assay showed antimicrobial activity in the presence of the agents both singly and in combination. Increasing the viscosity of chitosan from low to high effectively increases the respective molecular weight and polymeric chain length [42] , which results in potentially greater inter-chain entanglement, hence affecting its viscosity and ability to release the antimicrobial agents. The antimicrobial activity of the formulations will be discussed separately based on the type of agent and chitosan viscosity.
The effect of TTO-hydrogel (low viscosity) formulations follows an order of sensitivity similar to that of the minimum lethal concentration (MLC) reported in Low et al. (2011) [43] for free TTO, i.e., C. albicans > S. aureus ě P. aeruginosa ( Figure 4A ). Results showed little changes in the zones of inhibition (ZOI) against P. aeruginosa, possibly due to the higher tolerance of P. aeruginosa to TTO. In Figure 4A , the formulations C L1.25(17) Na-P 25(17) TTO 35(8) -C L2.5(7) Na-P 25(9) TTO 35(5) vary with increasing viscosity and amount of crosslinker which can improve gel stability. This resulted in more stable TTO hydrogels which can entrap more of the essential oil; the improved antimicrobial activity is observed by an increased ZOI for microorganisms with higher TTO sensitivity, e.g., C. albicans. Despite increased formulation stability (C L1.25(17) Na-P 25(17) TTO 35(8) -C L2.5(7) Na-P 25(9) TTO 35(5) ), the ZOI for less sensitive microorganisms, e.g., P. aeruginosa and S. aureus, has not been significantly affected (p > 0.05). This may be due to the slower rate of TTO release (from more stable hydrogels) which limits the availability of the agent at microbiocidal concentrations, and thus the ZOI for less sensitive microorganisms are not affected. Conversely, formulation C L2.5(10) Na-P 50(7) TTO 35(4) had the lowest chitosan: Na-P ratio which makes it less stable and more prone to faster erosion and drug release, resulting in a burst release of TTO which leads to a higher ZOI after 24 h incubation. Such immediate burst release with concomitant rapid hydrogel erosion is not particularly useful when treating wounds with heavy microbial loads. Formulations therefore need to be optimised to reduce the rate of erosion and degradation of the hydrogel whilst maintaining prolonged delivery of agents at microbiocidal concentrations. . Antimicrobial activity of TTO-hydrogels formulated with (A) low viscosity chitosan, (B) medium viscosity chitosan and (C) high viscosity chitosan. Error bars represent the standard deviation and n = 3. In all control experiments (using hydrogels without TTO), there was no observed zone of inhibition (ZOI) (data not shown). Statistical analysis using ANOVA indicated a significant difference in the antimicrobial activity of the formulations against the selected microorganisms (p < 0.05). The codes shown in the figure key describes the following: C L1.25 = 1.25% w/v low viscosity chitosan, C L2.5 = 2.5% w/v low viscosity chitosan, C M1.25 = 1.25% w/v medium viscosity chitosan, C M2.5 = 2.5% w/v medium viscosity chitosan, C H1.25 = 1.25% w/v high viscosity chitosan, C H2.5 = 2.5% w/v high viscosity chitosan, Na-P 25 = 25% w/v sodium phosphate, Na-P 50 = 50% w/v sodium phosphate, TTO 35 Results from Figure 4B did not show significant ZOI changes with increasing stability (C M2.5(11.75) Na-P 25(4.25) TTO 35(5) -C M1.25(12) Na-P 50(5) TTO 35(4) ) against P. aeruginosa. The ZOI in hydrogels C M2.5(12.5) Na-P 50(2.5) TTO 35(4) and C M1.25(12) Na-P 50(5) TTO 35(4) follows the MLC sensitivity trend of C. albicans > S. aureus > P. aeruginosa. However, the extent of antimicrobial activity, especially against the more sensitive C. albicans, is lower than those formulated with low-viscosity chitosan (C L2.5(10) Na-P 50(7) TTO 35(4) -C L2.5(7) Na-P 25(9) TTO 35(5) ). This reduce in antimicrobial activity is probably due to the overall increase in chitosan chain length (moving from low to medium viscosity), which potentially increases inter-chain entanglement, hence retarding the ability of TTO diffusion and thereby reducing the amount released from the hydrogel structure. Within this group, formulation C M2.5(12.5) Na-P 50(2.5) TTO 35(4) (lowest chitosan:Na-P ratio) forms a less stable hydrogel with a higher rate of erosion; the reduced crosslinking also contributes to a less stable gel network to maximise TTO:PVA encapsulation by allowing chain entanglement interactions between PVA and chitosan. As a result, TTO escape from the hydrogel may again follow a burst release profile and increase the ZOI for C. albicans and S. aureus. However, the concentration was insufficient to show a clear ZOI for P. aeruginosa, although there was an observed zone of restricted growth with an average diameter of 30.33 mm. Formulations C M2.5(12) Na-P 25(5) TTO 35(4) and C M1.25(12) Na-P 50(5) TTO 35(4) are more stable due to their increased viscosity (there is more chitosan in the formulation which is not diluted by the addition of aqueous Na-P). Despite having the same chitosan:Na-P ratio, the antimicrobial performance of C M2.5(12) Na-P 25(5) TTO 35(4) and C M1.25(12) Na-P 50(5) TTO 35(4) was different. This may be due to the variations in Na-P concentration, which can alter crosslinking and viscosity of hydrogels (C M2.5(12) Na-P 25(5) TTO 35(4) formulated using 25% w/v Na-P, C M1.25(12) Na-P 50(5) TTO 35(4) formulated using 50% Na-P). Such properties include both the viscosity of the various chitosan solutions and the ability of oppositely charged crosslinking phosphate anions to diffuse into the solution and form an electrostatically crosslinked semi-solid structure. The order of sensitivity in formulation C M2.5(11.75) Na-P 25(4.25) TTO 35(5) was altered to S. aureus > C. albicans > P. aeruginosa, which could have resulted from the higher concentration of TTO present in the hydrogels. Figure 4C showed that antimicrobial activity of hydrogels formulated with high-viscosity chitosan against C. albicans increased with increasing viscosity. The ZOI against S. aureus remained fairly consistent, possibly due to the increased gel stability and higher encapsulation of TTO and its components, which are subsequently available for release. Formulation C H2.5(10) Na-P 50(1) TTO 35(4) PVA 10(6) -C H2.5(22) Na-P 50(7) TTO 35(8) PVA 10(5) showed no clear ZOI against P. aeruginosa; however, similar to formulation C M1.25(12) Na-P 50(5) TTO 35(4) , there was an insufficient concentration of TTO to result in a clear ZOI and zones of restricted growth with average diameters of 13.5 mm (C H2.5(10) Na-P 50(1) TTO 35(4) PVA 10(6) ), 33.0 mm (C H1.25(13) Na-P 50(4) TTO 35(4) ) and 30.667 mm (C H2.5(22) Na-P 50(7) TTO 35(8) PVA 10(5) ) were observed. Formulation C H1.25(10) Na-P 25(7) TTO 35(4) was shown to have a ZOI against P. aeruginosa. The results in Figure 4 indicated that changes in hydrogel composition can affect their respective antimicrobial activities, possibly due to alterations in physicochemical properties of the gels.
The activity of Ag + hydrogels will be discussed based on the viscosity of chitosan and concentration of AgNO 3 because it has electrostatic crosslinking properties that affect the stability of the resultant hydrogels as well as their antimicrobial activity. In Ag + hydrogels, the order of sensitivity also follows the MLC order of Ag + reported in Low et al., 2011 [43] , i.e., C. albicans > P. aeruginosa ě S. aureus (Figure 5 ), when the concentration of Ag + is >0.2117% w/v. However, when the concentration is ď0.2117% w/v Ag + (formulation C L2.5(28) Ag 2(7) PVA 10(7) , C L2.5(10.5) Ag 0.75(7) PVA 10(3.5) , C M2.5(10) Ag 1(5) PVA 10(6) , C M2.5(7) Ag 1(7) PVA 10(7) and C H2.5(14) Ag 2(2) PVA 10(5) ), the order changes to P. aeruginosa > S. aureus ě C. albicans. Experimental results also showed that as Ag + diffuses into the MEA, a precipitate is formed in the agar. This can reduce the bioavailability of Ag + against C. albicans, resulting in a shift in the order of sensitivity. Despite its role as a crosslinker, the antimicrobial activity of Ag + is not affected if there are sufficient metal ions available for release from the hydrogel matrix (refer to Figure 5 ). Figure 5 ). In Figure 5A , formulations with >0.2117% w/v Ag + (CL1.25 (9)Ag2 (12)-CL1.25(8)Ag2 (13)) all showed a ZOI against C. albicans, unlike formulations CL2.5(28)Ag2 (7)PVA10 (7) and CL2.5(10.5)Ag0.75(7)PVA10(3.5). The observed ZOI was not influenced by the small increase in Ag + concentration from 0.635% to 0.786% In Figure 5A , formulations with >0.2117% w/v Ag + (C L1.25(9) Ag 2(12) -C L1.25 (8) Ag 2(13) ) all showed a ZOI against C. albicans, unlike formulations C L2.5(28) Ag 2(7) PVA 10(7) and C L2.5(10.5) Ag 0.75(7) PVA 10(3.5) . The observed ZOI was not influenced by the small increase in Ag + concentration from 0.635% to 0.786% w/v. All formulations showed a ZOI against P. aeruginosa and S. aureus. The increase in Ag + from C L1.25 (9) Ag 2(12) to C L1.25 (8) Ag 2(13) showed a gradual increase in ZOI, although this increase was not significant (p > 0.05). This may be due to the higher free Ag + MLC of P. aeruginosa (1.59ˆ10´3 % w/v) and S. aureus (5.08ˆ10´3 % w/v) compared to C. albicans (6.35ˆ10´4 % w/v) [43] . Medium-viscosity chitosan hydrogels ( Figure 5B) showed relatively similar ZOI when compared to those in Figure 5A with comparable amounts of Ag + (C L2.5(28) Ag 2(7) PVA 10 (7) and C M2.5(10) Ag 1(5) PVA 10(6) ; C L2.5(10.5) Ag 0.75(7) PVA 10(3.5) and C M2.5(7) Ag 1(7) PVA 10 (7) ). Formulations C M1.25 (22) Ag 2(20) and C M1.25(10.5) Ag 2(10.5) also showed a similar order of sensitivity as observed in C L1.25(9) Ag 2 (12) . The increased viscosity in C M1.25 (22) Ag 2(20) and C M1.25(10.5) Ag 2(10.5) may increase entrapment of Ag + within the hydrogel, leading to a slight increase in the ZOI against P. aeruginosa and S. aureus. However, this is not observed in C. albicans, as the slower release lowered the availability of Ag + , making it difficult to overcome the reaction with MEA and to express antimicrobial activity.
CM2.5(10)
A similar trend applies when hydrogels formulated with high-viscosity chitosan were used, e.g., formulation C H1.25 (14) Ag 2(10.5) in Figure 5C . The higher viscosity of hydrogels in Figure 5C altered the order of sensitivity to P. aeruginosa being most sensitive, followed by C. albicans and S. aureus. Disregarding C. albicans, this trend of sensitivity showed similarities to the results obtained from the MLC of free Ag + [43] . In addition to the high viscosity, the interaction between the Ag + and MEA makes it more difficult to monitor the actual extent of antimicrobial activity against C. albicans.
According to Figure 6 , the order of sensitivity generally follows the MLC response for free agents reported in Low et al., 2011 [43] , i.e., C. albicans > P. aeruginosa > S. aureus, for low-and medium-viscosity but not high-viscosity chitosan hydrogels. Formulation C L1.25 (12) TTO-Ag 20´0.5p3q Na-P 25(1) PVA 10(5) -C L1.25(9.5) TTO-Ag 20´1p11.5q ( Figure 6A ) shows that the antimicrobial activity of the hydrogels is dependent on the viscosity and Ag + content in the system. Higher viscosity with increased Ag + forms gels with better stability for entrapment of agents and reduces burst release of agents via erosion. Nevertheless, such properties may allow controlled release to be achieved for sustained antimicrobial activity against less sensitive microorganisms. Small increments in ZOI of the microorganisms were observed as the concentration of agents increased (formulations C L1.25 (12) TTO-Ag 20´0.5p3q Na-P 25(1) PVA 10(5) -C L1.25(9.5) TTO-Ag 20´1p11.5q , except C L1.25 (12) TTO-Ag 20´0.5p3q Na-P 25(1) PVA 10(5) against C. albicans). The lower Ag + content in C L1.25 (12) TTO-Ag 20´0.5p3q Na-P 25(1) PVA 10(5) may reduce crosslinking to enable a faster release of TTO. Thus, the observed higher ZOI may be due to C. albicans having higher sensitivity to TTO. Similarly, this was also observed in the ZOI of formulations C M2.5(11) TTO-Ag 20´1p6q PVA 10(4) , C M2.5(7) TTO-Ag 20´1p7q PVA 10(7) and C M1.25(10) TTO-Ag 20´1p11q ( Figure 6B ) against C. albicans. The higher concentration of TTO in formulation C M2.5(7) TTO-Ag 20´1p7q PVA 10(7) (0.1058% w/v Ag + and 13.333% v/v TTO) resulted in the higher C. albicans ZOI compared to a relatively similar counterpart, formulation C M2. formulation CM2.5(11)TTO-Ag20-1(6)PVA10(4) (0.1814% w/v Ag + and 5.7143% v/v TTO). The ZOI of S. aureus and P. aeruginosa remained fairly consistent between formulations CM1.25(12)TTO-Ag20-0.5(3)Na-P25(0.75)PVA10(5.25)-CM1.25(10)TTO-Ag20-1 (11) .
High-viscosity chitosan hydrogels ( Figure 6C ) showed slight variation from the MLC data. The order of sensitivity is P. aeruginosa ≥ C. albicans > S. aureus. Similar to all the other formulations, the overall viscosity of the system, the crosslinking capacity of Ag + and the amount of TTO affect the antimicrobial activity of the formulations. Nevertheless, hydrogels containing both TTO and Ag + managed to maintain their antimicrobial activity despite having agent concentrations lower than those in TTO or Ag + hydrogels. For example, formulation CH2.5(21.5)TTO-Ag20-1(3.5)PVA10 (14), containing 0.0570% w/v Ag + and 1.795% v/v TTO, Figure 6 . Antimicrobial activity of Ag + + TTO: PVA hydrogels formulated with (A) low-viscosity chitosan; (B) medium-viscosity chitosan; and (C) high-viscosity chitosan. Error bars represent the standard deviation and n = 3. In all control experiments (using hydrogels without Ag + + TTO: PVA), there was no observed ZOI (data not shown). Statistical analysis using ANOVA indicated a significant difference in the antimicrobial activity of the formulations against the selected microorganisms (p < 0.05). The codes shown in the figure key describe the following: C L1.25 = 1.25% w/v low-viscosity chitosan, C L2.5 = 2.5% w/v low-viscosity chitosan, C M1.25 = 1.25% w/v medium-viscosity chitosan, C M2.5 = 2.5% w/v medium-viscosity chitosan, C H1.25 = 1.25% w/v high-viscosity chitosan, C H2.5 = 2.5% w/v high-viscosity chitosan, TTO-Ag 20´0.5 = 40% TTO: 0.5% AgNO 3 , TTO-Ag 20´1 = 40% TTO: 1.0% AgNO 3 , Na-P 25 = 25% w/v sodium phosphate, PVA = PVA 30-70 kDa and the volume of the components used in each formulation are shown in the brackets.
High-viscosity chitosan hydrogels ( Figure 6C ) showed slight variation from the MLC data. The order of sensitivity is P. aeruginosa ě C. albicans > S. aureus. Similar to all the other formulations, the overall viscosity of the system, the crosslinking capacity of Ag + and the amount of TTO affect the antimicrobial activity of the formulations.
Nevertheless, hydrogels containing both TTO and Ag + managed to maintain their antimicrobial activity despite having agent concentrations lower than those in TTO or Ag + hydrogels. For example, formulation C H2.5(21.5) TTO-Ag 20´1p3.5q PVA 10(14) , containing 0.0570% w/v Ag + and 1.795% v/v TTO, maintained antimicrobial activity when compared to similar formulations (e.g., C H2.5(14) Ag 2(2) PVA 10(5) containing 0.0605% w/v Ag + , and C H2.5(10) Na-P 50(1) TTO 35(4) PVA 10(6) containing 6.6667% v/v TTO). At low concentrations of Ag + , formulation C H2.5(14) Ag 2(2) PVA 10(5) did not show a clear ZOI against C. albicans, while formulation C H2.5(10) Na-P 50(1) TTO 35(4) PVA 10(6) did not show a clear ZOI against P. aeruginosa, despite having higher TTO content. The ZOI observed for S. aureus remained fairly consistent when comparing the hydrogels formulated with varying chitosan viscosity. The maintenance of activity when using both agents at lower concentrations demonstrates the feasibility of using combined agents at lower effective concentrations.
Incorporation of TTO and/or Ag + into chitosan hydrogels demonstrated the possibility of maintaining antimicrobial activity when using a delivery system. The capacity and performance of antimicrobial agents varies depending on the type of dressing and wound. For the treatment of moist wounds, e.g., ulcers, the absorptive properties of hydrogels make them a better option compared to non-absorptive dressings such as gauzes. Research indicated that there is no single dressing that can produce the optimum microenvironment for all wounds [44] , thus the characteristics of formulations and delivery systems need to be tailored to suit the wound site.
Factors such as the differences in physicochemical properties of the hydrogels, including chitosan viscosity, concentration of the crosslinker (Na-P or AgNO 3 ) and the amount of available antimicrobial agent (Ag + or TTO), may result in the observed varying order of sensitivity between formulations. Low-, medium-and high-viscosity chitosans derive their rheological properties from the increasing chain length of the polymer. Within each of these groups the concentration of chitosan and the degree of crosslinking also influence viscosity. In addition, increasing the amount of Na-P improves crosslinking and increases hydrogel stability.
Changes in TTO composition in the hydrogels may occur due to the loss of volatile TTO components during the gel setting period. The availability of Ag + varies according to the concentration required for crosslinking (AgNO 3 donates the anionic crosslinking nitrate group) and the release of Ag + from the hydrogel.
Encapsulation of broad spectrum antimicrobial agents (TTO and/or Ag + ) into hydrogel-based formulations may be a feasible option to enhance biodistribution and biological activity of the agents. Despite the effectiveness of combined treatments, the toxicity of individual agents towards human host cells should also be carefully considered. Although toxicity or irritancy are less likely to occur, various reports of toxicity associated with the misuse/overuse of TTO [12, 45] , Ag + and silver-containing products have been discussed [10, 26, 28] . Thus, it is important to find an effective lower combination ratio of TTO and Ag + concentrations to avoid toxicity issues whilst maintaining antimicrobial properties. In this investigation, PVA was used to emulsify TTO to form an oil-in-water emulsion. This will allow more efficient encapsulation into the hydrogels, reducing loss and degradation of volatile components which may affect the oil's therapeutic activity [37, 44] . Emulsifying essential oils can also improve hydrophobic and hydrophilic component distribution due to reduced droplet size [44] . The release kinetics of agents incorporated into chitosan gels may be influenced by factors such as the morphology, size, density, extent of crosslinking, gel formulation ability and swelling of the chitosan-based hydrogel [46] .
Conclusions
The versatility of these agent(s) against a wide range of different microorganisms due to their multiple target sites might be used to improve the current treatment strategies for various chronic wound infections. Combining agents with different intra-and extracellular target sites has two advantages. One is to limit the development of resistance towards these antimicrobial compounds by extending the range of target sites. The activity of microbial agents with a single site of action can much more readily be overcome, thus making it easier for resistance to develop. Another advantage is to reduce the likelihood of toxic effects.
This study showed the feasibility of developing hydrogels as a controlled release system for the delivery of TTO and Ag + in combination. As a whole, the results from this investigation have provided the basis to develop hydrogel formulations for the delivery of an essential oil (TTO) and metal ion (Ag + ) as antimicrobial agents for the treatment of acute wounds. The relationship between the variables in the hydrogel formulations and antimicrobial activity requires further work. Consequently, the characteristics of the hydrogel formulations, including the encapsulated agent concentration, can be modified to enhance their potential as a smart delivery system.
